Kikuchi Chigusa, Yamaguchi Kyoko, Kojima Masayo, Asai Haruyuki, Nakao Rika, Otake Yoshifusa, Nagata Junya, Matsunami Shinpei, Horiba Asako, Suzuki Tadashi
Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, 467-8603, Japan.
Educational Research Centre for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, 467-8603, Japan.
J Pharm Health Care Sci. 2020 Nov 23;6(1):24. doi: 10.1186/s40780-020-00182-8.
While the world's population is growing older, healthy life expectancy is not increasing. The Japanese Orthopedic Association proposed the concept of 'locomotive syndrome,' manifested as a decline in mobility functions, and introduced a short test battery for assessing the risk of this syndrome. The test battery includes the 'stand-up test,' 'two-step test,' and '25-question Geriatric Locomotive Function Scale' (25-question GLFS). The purpose of locomotion training is to improve and sustain standing and gait functions. However, the place where locomotion training can be provided and followed up has not been decided upon. Therefore, a study was conducted to explore the effect of locomotive syndrome improvement by continuous locomotion training provided at community pharmacies. The objective of this study was to evaluate the effect of pharmacists' instructions and follow-up on the compliance and effectiveness of locomotion training.
The inclusion criteria were 1) age ≥ 65 years and 2) decline in mobility functions. Guidance on how to perform locomotion training was provided by a pharmacist at the pharmacy. The participants performed locomotion training at home. They were tested and instructed at the pharmacy once a month for 3 months. The main outcome measures were test battery results and the percentage of number of days participants who were able to do the training at home.
Eleven participants were analysed. The minimum implementation percentage was 78%. Improvements were observed in 25-question GLFS, muscle strength, and standing time on one leg. Three participants no longer showed a noticeable decline in mobility function.
Continuous locomotion training provided at pharmacies could contribute to locomotive syndrome prevention.
This study was registered with the University hospital Medical Information Network Clinical Trials Registry (UMIN-CTR; identification No. UMIN000027963 . Registered 28 June 2017).
尽管世界人口老龄化，但健康预期寿命并未增加。日本骨科协会提出了“运动机能不全综合征”的概念，表现为运动功能下降，并引入了一套简短的测试组合来评估该综合征的风险。该测试组合包括“起立测试”“两步测试”和“25项老年运动机能功能量表”（25项GLFS）。运动训练的目的是改善和维持站立及步态功能。然而，能够提供并跟进运动训练的场所尚未确定。因此，开展了一项研究，以探讨社区药房提供的持续运动训练对改善运动机能不全综合征的效果。本研究的目的是评估药剂师的指导和跟进对运动训练依从性及有效性的影响。
纳入标准为：1）年龄≥65岁；2）运动功能下降。药剂师在药房提供如何进行运动训练的指导。参与者在家中进行运动训练。他们在药房每月接受一次测试和指导，为期3个月。主要结局指标为测试组合结果以及在家中能够进行训练的参与者天数百分比。
对11名参与者进行了分析。最低实施百分比为78%。在25项GLFS、肌肉力量和单腿站立时间方面观察到改善。3名参与者的运动功能不再有明显下降。
药房提供的持续运动训练有助于预防运动机能不全综合征。
本研究已在大学医院医学信息网络临床试验注册中心（UMIN-CTR；识别号UMIN000027963。于2017年6月28日注册）注册。
